The symmetrical bisheterocycles built around varying lengths aliphatic linkers have been synthesized from the easy cyclization reactions of bischalcones with phenyl hydrazine by refluxing in dry EtOH and glacial acetic acid medium. The intermediates in turn were prepared in the good yields from O-alkylation of hydroxy substituted chalcone with suitable 1,x-dibromoalkanes in the presence of anhydrous K 2 CO 3 , dry acetone and Bu 4 N +
Introduction
Five membered heterocyclic compounds containing two nitrogen atoms such as substituted pyrazolines [1] [2] [3] have played a vital role in discovering novel compounds exhibiting various biological activities such as antitumor [4] , anti-inflammatory [5] [6] [7] , MAO-B inhibitors [8, 9] , agonist of cannabinoid receptors [10] , antioxidant [11] [12] [13] , antihypertensive [14] , anticancer [15] [16] [17] [18] [19] [20] , antidepressant [21] [22] [23] , antiamoebic [24] and as CB 2 receptor [25] . Recently these compounds are also reported to possess potential antiviral activity against flavivirus [26] and HIV [27] . Among these heterocycles, 2-pyrazolines display a broad spectrum of potential pharmacological activities [28] [29] [30] 6, 31, 7, 5, [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] and are present in a number of drug molecules such as phenazone [43] 1 (anti-inflammatory and antipyretic), methampyrone [44] 2 (analgesic and antipyretic), azolid [45] 3 (anti-inflammatory), tandearil [46] 4 (anti-inflammatory) & anturan [47] 5 (uricosuric), etc ( Figure 1 ). These compounds are prepared by the cyclization reaction of chalcones with hydrazine derivatives [48] . A number of applications such as dyestuff's analytical reagents [49] and agrochemicals [50] are also found to be associated with the chalcones. Keeping these synthetic applications in mind and inspired by our previous researches on bisheterocyclics [51] [52] [53] , we report herein the 2.2. Synthesis of (2E,2 0 E)-1,1 0 -(4,4 0 -ethane-1,2diylbis(oxy))bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1one 8a
A suspension of chalcone (2.14 g, 0.01 mol), 1,2-dibromoethane (0.93 g, 0.005 mol) and tetrabutylammonium iodide (1.0 g) and anhydrous K 2 CO 3 in dry acetone (25 mL) was refluxed for 6 h with continuous stirring. The progress of reaction was monitored by TLC. After the completion of reaction, the reaction mixture turned to a colorless mass which was poured into iced-HCl to obtain a crude product that was crystallized with MeOH to yield a pure bischalcone 8a. 2.3. Synthesis of (2E,2 0 E)-1,1 0 -(4,4 0 -propane-1,3diylbis(oxy))bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1one 8b
The bischalcone 8b was obtained from the reaction of chalcone 2 (2.14 g, 0.01 mol) with 1,3-dibromopropane (1.00 g, 0.005 mol) under the similar conditions as described above for 8a. The bischalcone 8c was synthesized from the reaction of chalcone 7 (2.14 g, 0.01 mol) with 1,4-dibromobutane (1.07 g, 0.005 mol) under the similar conditions as discussed earlier for 8a. 2.5. Synthesis of (2E,2 0 E)-1,1 0 -(4,4 0 -pentane-1,5-diylbis(oxy)) bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1-one 8d
The bischalcone 8d was prepared by reacting chalcone 7 (2.14 g, 0.01 mol) with 1,5-dibromopentane (1.14 g, 0.005 mol) under the similar conditions as explained earlier for 8a. 
The bischalcone 8e was obtained from the reaction of chalcone 7 (2.14 g, 0.01 mol) with 1,6-dibromohexane (1.22 g, 0.005 mol) under the similar conditions as described above for 8a. 2.9. Synthesis of (2E,2 0 E)-1,1 0 -(4,4 0 -dodecane-1,12diylbis(oxy))bis(4,1-phenylene)bis(3-furan-2-yl)prop-2-en-1one 8h
The bischalcone 8h was synthesized by reacting chalcone 7 (2.14 g, 0.01 mol) with 1,12-dibromododecane (1.64 g, 0.005 mol) under the similar conditions as explained earlier for 8a. The compound 9d was prepared by treating bischalcone 8d (1.0 g, 0.002 mol) with phenyl hydrazine (0.43 g, 0.004 mol) under similar conditions as described earlier for 9a. The compound 9e was synthesized by treating bischalcone 8e (1.0 g, 0.0019 mol) with phenyl hydrazine (0.42 g, 0.0039 mol) under similar conditions as discussed above for 9a.
Antimicrobial activity
All the newly prepared compounds 8(a-h) and 9(a-h) were also screened for the antibacterial and antifungal activities against seven bacterial and five fungal strains namely Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, Pseudomonas fluorescens, Bacillus subtilis, Staphylococcus aureus, Staphylococcus pyrogen and Fusarium oxysporum, Aspergillus sclerotium, Aspergillus niger, Penicillium glabrum, Aspergillus janus respectively. The minimum inhibitory concentration (MIC) of these synthesized compounds were screened in vitro by using the serial tube dilution method at concentration 128, 64, 32, 16, 8 and 4 lg/mL against the above said microorganisms. The bacterial strains were subcultured on nutrient agar medium whereas fungal strains were subcultured on malt extract medium. The bacterial and fungal strains were incubated at 37°C and 28°C. DMSO was used as a negative control while Amoxicillin and Fluconazole were used as reference drugs for comparison. The minimum inhibitory concentrations (MIC) of all the studied compounds were noted by the Furyl based new bispyrazolines linked via aliphatic chains appearance of turbidity in test tubes after incubation. The results of the MIC determinations of these compounds have been presented in Table 1 {8(a-h)} and Table 2 {9(a-h)}.
It is evident from Table 1 that compounds 8a & 8f exhibited significant activities against S. pyrogen & A. sclerotium, P. glabrum respectively at MIC of 8 lg/mL whereas compound 8h was found to be more active against P. fluorescens at MIC of 4 lg/ mL which is comparable to standard drug Amoxicillin. Table 2 clearly describes that some of the bispyrazolines exhibited moderate to good activity against the tested antimicrobial strains. Compounds 9b & 9d inhibited the growth of P. fluorescens & A. sclerotium at MIC of 8 lg/mL respectively. The compounds 9b, 9e and 9f were found to be significantly active against B. subtilis. Compound 9h could provide most significant (MIC-4 lg/mL) against Pseudomonas fluorescens which is equal to standard drug used. So, it is clear from Tables 1 and 2 that most of the synthesized compounds showed moderate to significant activities against the tested microorganisms. The compounds 8a, 8f, 8h, 9b, 9e, 9f & 9h were found to be promising antimicrobial agents.
Conclusion
This study provides the general method for the preparation of new bispyrazolines linked through alkyl chains of varying length. The products have been obtained under the normal conditions without using any specific and toxic reagent. The antimicrobial analysis of the prepared bischalcones and bispyrazolines has also been carried out and newly prepared compounds 8h & 9h showed most significant results (MIC-4 lg/mL) against P. fluorescens which is comparable to standard drug. Further investigations regarding the more biological studies of these compounds could be helpful in designing the potent antimicrobial agents.
